Testing effectiveness (Phase 2)Study completedNCT03455842What this trial is testingThe BCD-089 (aIL6R) in Patients With Active Rheumatoid ArthritisWho this might be right forSeropositive RA Biocad 105
Early research (Phase 1)Looking for participantsNCT06946199What this trial is testingAn Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis (RA) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 28
Testing effectiveness (Phase 2)Ended earlyNCT00634933What this trial is testingStudy Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid ArthritisWho this might be right forArthritis, Rheumatoid Pfizer 222
Testing effectiveness (Phase 2)Study completedNCT00147966What this trial is testingAssessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)Who this might be right forRheumatoid Arthritis University of California, San Diego 24
Not applicableStudy completedNCT06670144What this trial is testingDiet and Rheumatoid Arthritis Risk in the United Kingdom Women's CohortWho this might be right forRheumatoid Arthritis (RA) University of Leeds 35,372
Not applicableStudy completedNCT04356183What this trial is testingWeight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular RiskWho this might be right forRheumatoid Arthritis Duke University 24
Large-scale testing (Phase 3)Active Not RecruitingNCT04909801What this trial is testingCompare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Bristol-Myers Squibb 338
Not applicableStudy completedNCT02581852What this trial is testingWorkability in Patients With Seropositive Rheumatoid ArthritisWho this might be right forSeropositive Rheumatoid Arthritis Kaiser Franz Josef Hospital 100
Early research (Phase 1)Active Not RecruitingNCT07052032What this trial is testingAn Open-label Study of CND261 in Seropositive Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Candid Therapeutics 47